Allarity Therapeutics, Inc. has announced the expansion of their Phase 2 clinical trial for stenoparib, a dual PARP/Wnt pathway inhibitor, aimed at treating advanced ovarian cancer. Their recent decision seeks to accelerate the drug's clinical development and work towards FDA regulatory
Clinical trials are fundamental to the development of new medical treatments and the advancement of healthcare. However, enrolling and retaining participants in these trials has been a persistent challenge over the years. The perceived difficulty of involvement, alongside high dropout rates, can
The 21st century has seen the pharmaceutical industry face mounting challenges such as escalating competition and pricing pressures. Consequently, developers and manufacturers are pioneering innovative strategies to differentiate their products and instill value, particularly in the saturated
The healthcare investment landscape has undergone significant transformations in recent years, driven by various factors including the COVID-19 pandemic, technological advancements, and strategic shifts within the industry. As we delve into 2024, it is crucial to understand the key trends and
In a groundbreaking development, the recent trials of a drug developed by Ireland-based psychedelics biotech company GH Research have showcased its potential in treating treatment-resistant depression. The mid-stage clinical trial, comprising 81 participants, revealed a significant reduction in
In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and
